Phathom Pharmaceuticals, Inc.

NasdaqGS:PHAT

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 736.40 M

Share Price

USD 10.38

Avg Daily Volume

2,341,824

Change (1 day)

0.97%

Change (1 year)

-13.72%

Change (YTD)

27.83%

Phathom Pharmaceuticals, Inc. Common Stock Issued for the Trailing 12 Months (TTM) ending August 13, 2025: N/A

Phathom Pharmaceuticals, Inc. Common Stock Issued is NA for the Trailing 12 Months (TTM) ending August 13, 2025. Common stock issued is cash received from issuing new shares of the company’s common stock.

Competitors

Eli Lilly and Company

USD 639.43

LLY

+4.21 0.66%

AbbVie Inc.

USD 198.64

ABBV

-0.06 -0.03%

Roche Holding AG

USD 320.12

RO.SW

+2.62 0.83%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novartis AG

USD 119.03

NOVN.SW

+1.05 0.89%

Novo Nordisk A/S

USD 50.00

NOVO-B.CO

-0.09 -0.18%

Merck & Co., Inc.

USD 80.30

MRK

+0.27 0.34%

Thermo Fisher Scientific Inc.

USD 477.41

TMO

+15.02 3.25%

Amgen Inc.

USD 284.98

AMGN

-0.11 -0.04%

Gilead Sciences, Inc.

USD 120.02

GILD

-0.45 -0.37%

Pfizer Inc.

USD 24.65

PFE

+0.07 0.29%

Sanofi

USD 95.31

SAN.PA

+0.83 0.88%

Vertex Pharmaceuticals Incorporated

USD 387.77

VRTX

+13.31 3.55%

Bristol-Myers Squibb Company

USD 46.55

BMY

+0.62 1.35%

Chugai Pharmaceutical Co., Ltd.

USD 42.73

4519.T

+0.95 2.28%

View all

Key Data

Date	Common Stock Issued	Common Stock Repurchased	Free Cash Flow	Operating Cash Flow